Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now
In a new research report from Jefferies, many of the outstanding companies in pharmaceuticals and biotech space show up among the stocks to buy.
In a new research report from Jefferies, many of the outstanding companies in pharmaceuticals and biotech space show up among the stocks to buy.
One smart thing for growth stock buyers is to focus on total return and buy large cap quality stocks that will do well regardless of the near-term economic news.
A new research report from Deutsche Bank says it is time to increase precious metal exposure, and it has three top gold picks.
A recent Merrill Lynch research report features the firm's top ideas for the fourth quarter. These eight stocks look like outstanding picks for growth stock accounts.
SunTrust Robinson Humphrey is not alone in its praise of these three top semiconductor stock. They are widely covered on Wall Street and most firms are very bullish.
Regardless of what rates do, these four companies should do fine as they have very strong and mature businesses.
With the 10-year Treasury yielding much less than 2% and the prospects for big capital gains going forward far lower than over the past 10 years, switching to top dividend stocks now looks like…
Regardless of who ends up in the White House, the crumbling infrastructure in the United States is a huge issue, and both candidates know it needs to be addressed.
Corporations forbid employees from buying or selling company shares around the release of earnings for obvious reasons. Things may be ready to quiet down in October.
Given the fact that insider sales windows are closing fast as third-quarter earnings are imminent, it is pretty easy to understand the spike in selling volume we saw this past week.
Merrill Lynch feels an OPEC production cut in November could push market share to non-OPEC producers, especially those in the U.S. shales, and that in turn could be big for oilfield services.
Any of these three top pharmaceutical companies makes an outstanding addition to more conservative portfolios. They are also far less volatile and act better than biotechs if the market gets dicey.
These four companies have plenty on their proverbial plates and could be poised to move higher if their near-term and longer-term catalysts play out.
24/7 Wall St. has searched its research database for international integrated oil companies that may be the winners in a race to supply an oil-thirsty China.
In a Jefferies research report, the top growth stock picks for this week are littered with outstanding biotech companies that could be poised for some big moves.
In a recent research note, the analysts at Merrill Lynch make a big move by adding a top utility company to the firm's well-respected US 1 list of stocks to Buy.
In a new research report on internet stocks, the analysts at JPMorgan make the case that owning these market leaders still makes sense despite in some cases almost meteoric rises from the lows in…
The question for many investors who have purchased higher yielding bond proxies like utilities, real estate investment trusts and energy master limited partnerships is what sector will act the best when interest rates tick…
The question for investors getting nervous about the market, the election and the general state of the global macro picture is what stocks will hold up best if we do get hit hard.
The longevity of these four top technology companies that all pay a very solid and increasing dividend is a testament to current and former executives who steered them into new product arenas to compete…